open menu
Corporate Information

As a company, we enhance the value of our shareholders and protect corporate and societal values

General Meeting of Shareholders

Status of Exercising Voting Rights in the 4th Ordinary General Meeting of Shareholders

(단위 : 주)
제4기 정기 주주총회 의결권 행사 현황
Agenda Resolution category Purpose (agenda) items of the meeting Approved or not Total number of shares issued with voting rights (①) Number of shares with voting rights (A) among those under ① 2) Number of assenting shares (B) (attendance rate, %) 3)
Number of opposing or abstaining votes (C) (ratio, %) 4)
Agenda No. 1 Normal Approval of the 4th-Term (2021.01.01 ~ 2021.12.31)
Financial Statements
Approved 3,177,795 2,004,992 1,961,468 (97.83%)
43,524 (2.17%)
Agenda No. 2 Special Partial modification of the Articles of Association Approved 3,177,795 2,004,992 2,004,992 (100.00%)
0 (0.00%)
Agenda No. 3 Agenda No. 3-1 Agenda No. 3-1-1 Normal Appointment of Internal Director Lee Geon-jong Approved 3,177,795 2,004,992 1,960,565 (97.78%)
44,427 (2.22%)
Agenda No. 3-1-2 Normal Appointment of Internal Director Lee Cheon-seok Approved 3,177,795 2,004,992 2,003,983 (99.95%)
1,009 (0.05%)
Agenda No. 3-2 Agenda No. 3-2-1 Normal Approval of Outside Director as Audit Committee member Approved 1,914,532 741,729 718,759 (96.90%)
22,970 (3.10%)
Agenda No. 3-3 Agenda No. 3-3-1 Normal Appointment of Outside Director Wang Yun-jong Approved 3,177,795 2,004,992 1,993,633 (99.43%)
11,350 (0.57%)
Agenda No. 3-2-2 Normal Appointment of Outside Director Lee Chang-jae Approved 3,177,795 2,004,992 1,615,493 (80.57%)
389,499 (19.43%)
Agenda No. 4 Agenda No. 4-1 Normal Approval of Wang Yun-jong as Audit Committee member Approved 1,914,532 741,729 732,972 (98.82%)
8,757 (1.18%)
Agenda No. 4-2 Normal Approval of Lee Chang-jae as Audit Committee member Approved 1,914,532 741,729 629,078 (84.81%)
112,651 (15.19%)
Agenda No. 5 Normal Approval of director remuneration limit Approved 3,177,795 2,004,992 1,524,760 (76.05%)
480,232 (23.95%)

※ Participating number of shares and ratio excluding the largest shareholders and specially related persons:
Agenda Nos. 1, 2, and 5 and Agenda Nos. 3-1 and 3-3 were 606,669 shares and 34.11% (606,669 shares/1,778,809 shares)

페이지 네비게이션